~~<i id='B896B1555F'><strike id='B896B1555F'><tt id='B896B1555F'><pre id='B896B1555F'></pre></tt></strike></i>~~

Home» leisure time» explore

explore

author：entertainment 2025-09-29 05:48:18 Page View：856

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Blood tests recalled over risk of missed heart attack diagnosis
Next article： BioMarin wins approval for gene therapy to treat hemophilia A

comprehensive

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

Medicare will require more price transparency from hospitals

Medicarewillforcehospitalstobebetteraboutpublishingthepricestheychargehealthinsurersandpatients.DonP

In Memoriam: Notable people who died in 2023

1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

Biotech incubator Curie.Bio graduates its first startup

ChristophLengauer,co-founderandCSOofCurie.BioVanessaLeroyforSTATCurie.Bio,thenewbiotechinvestmentfir